Table 2 Baseline sociodemographic and clinical characteristics of the trial groups
CharacteristicPlacebo (n = 330)Amoxicillin (n = 330)p Value
Sociodemographic
    Age (y) (mean (SD))29.7 (9.4)29.8 (8.8)0.94
    Female205 (62.1)195 (59.1)0.38
    HIV infected66/330 (20.0)*65/329 (19.8)0.94
        CD4 counts (25, 75 percentiles)303 (119, 516)367 (197, 530)
    Cigarette smoker38/323 (11.8)40/326 (12.3)0.90
    Marital status
        Single109/328 (33.2)114/330 (34.5)
        Married/cohabiting202/328 (61.6)189/330 (57.3)
        Divorced/separated/widowed17/328 (5.2)27/330 (8.2)0.25
    Employed215/327 (65.7)235/330 (71.2)0.15
    Has savings103/327 (31.5)108/329 (32.8)0.74
    Education ⩽8 y164/327 (50.2)160/330 (48.5)0.70
Symptoms
    Shortness of breath108/323 (33.4)106/326 (32.5)0.80
    Chest pain240/323 (74.3)237/325 (72.9)0.72
    Wheezing149/323 (46.1)134/326 (41.1)0.21
    Duration of cough (days) (mean (SD))8.3 (4.3)8.4 (4.4)0.78
    Anorexia109/323 (33.7)117/326 (35.9)0.62
    Nausea58/323 (18.0)73/326 (22.4)0.20
    Vomiting21/323 (6.5)21/326 (6.4)0.87
    Abdominal pain58/323 (18.0)59/326 (18.1)1.0
    Diarrhoea14/323 (4.3)17/326 (5.2)0.71
  • Values are number (%) unless otherwise stated.

  • *Relevant denominator indicated.